Tapering versus cold turkey: symptoms versus successful discontinuation of menopausal hormone therapy.
作者信息
Suffoletto Jo-Anne, Hess Rachel
出版信息
Menopause. 2009 May-Jun;16(3):436-7. doi: 10.1097/gme.0b013e3181a057db.
Abstract
摘要
相似文献
1
Tapering versus cold turkey: symptoms versus successful discontinuation of menopausal hormone therapy.
Menopause. 2009 May-Jun;16(3):436-7. doi: 10.1097/gme.0b013e3181a057db.
2
Discontinuing postmenopausal hormone therapy: an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms?
Menopause. 2009 May-Jun;16(3):494-9. doi: 10.1097/gme.0b013e31818fbff5.
3
How best is to discontinue postmenopausal hormone therapy: immediate or tapered?
Maturitas. 2007 Jan 20;56(1):78-83. doi: 10.1016/j.maturitas.2006.06.006. Epub 2006 Oct 13.
4
Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
J Natl Cancer Inst. 2000 Jul 5;92(13):1100-1. doi: 10.1093/jnci/92.13.1100.
5
Guidelines for hormone treatment of women in the menopausal transition and beyond.
Maturitas. 2005 May 16;51(1):15-20. doi: 10.1016/j.maturitas.2005.02.007.
6
Changing concepts: Menopausal hormone therapy and breast cancer.
J Natl Cancer Inst. 2012 Apr 4;104(7):517-27. doi: 10.1093/jnci/djs014. Epub 2012 Mar 16.
7
Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes.
Am J Med. 2011 Mar;124(3):199-205. doi: 10.1016/j.amjmed.2010.09.021.
8
Different menopausal hormone regimens and risk of breast cancer.
Ann Oncol. 2018 Aug 1;29(8):1771-1776. doi: 10.1093/annonc/mdy212.
9
Estrogen replacement therapy and asthma.
Pulm Pharmacol Ther. 2013 Dec;26(6):617-23. doi: 10.1016/j.pupt.2013.08.004. Epub 2013 Sep 10.
10
The rationale for low-dose hormonal therapy.
Endocrine. 2004 Aug;24(3):217-21. doi: 10.1385/ENDO:24:3:217.
引用本文的文献
1
Menopausal Hormone Therapy in Older Women: Examining the Current Balance of Evidence.
Drugs Aging. 2023 Aug;40(8):675-683. doi: 10.1007/s40266-023-01043-3. Epub 2023 Jun 21.
2
Hormone replacement therapy (conjugated oestrogens plus bazedoxifene) for post-menopausal women with symptomatic hand osteoarthritis: primary report from the HOPE-e randomised, placebo-controlled, feasibility study.
Lancet Rheumatol. 2022 Sep 21;4(10):e725-e737. doi: 10.1016/S2665-9913(22)00218-1. eCollection 2022 Oct.
本文引用的文献
1
Discontinuing postmenopausal hormone therapy: an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms?
Menopause. 2009 May-Jun;16(3):494-9. doi: 10.1097/gme.0b013e31818fbff5.
2
Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.
Menopause. 2007 Mar-Apr;14(2):168-82. doi: 10.1097/gme.0b013e31803167ab.
3
How best is to discontinue postmenopausal hormone therapy: immediate or tapered?
Maturitas. 2007 Jan 20;56(1):78-83. doi: 10.1016/j.maturitas.2006.06.006. Epub 2006 Oct 13.
4
Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective study.
Menopause. 2006 May-Jun;13(3):370-6. doi: 10.1097/01.gme.0000186663.36211.c0.
5
Symptom experience after discontinuing use of estrogen plus progestin.
JAMA. 2005 Jul 13;294(2):183-93. doi: 10.1001/jama.294.2.183.
6
Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
Menopause. 2004 Jan-Feb;11(1):11-33. doi: 10.1097/01.GME.0000108177.85442.71.
7
Predictors of difficulty when discontinuing postmenopausal hormone therapy.
Obstet Gynecol. 2003 Dec;102(6):1233-9. doi: 10.1016/j.obstetgynecol.2003.09.025.
8
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321.
9
A 60-year-old woman trying to discontinue hormone replacement therapy.
JAMA. 2002 Apr 24;287(16):2130-7. doi: 10.1001/jama.287.16.2130.
Zotero 插件